GeoVax Labs, Inc. Logo

GeoVax Labs, Inc.

Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.

GOVX | US

Overview

Corporate Details

ISIN(s):
US3736786068
LEI:
Country:
United States of America
Address:
1900 LAKE PARK DRIVE, 30080 SMYRNA

Description

GeoVax Labs, Inc. is a clinical-stage biotechnology company that develops human vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms. The company's lead oncology program is Gedeptin®, a therapy for advanced head and neck cancers which has completed enrollment in a Phase 1/2 clinical trial. Its primary infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine being evaluated in Phase 2 clinical trials for high-risk, immunocompromised populations and as a heterologous booster. GeoVax's development pipeline also includes research programs for preventive vaccines against Mpox, smallpox, hemorrhagic fever viruses such as Ebola and Marburg, malaria, and Zika virus, alongside therapies for various solid tumors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-31 06:15 English 5.2 KB
2025-03-28 21:40
FORM PRE 14A
English 557.8 KB
2025-03-28 21:14
FORM 8-K
English 137.0 KB
2025-03-27 21:41
FORM POS AM
English 1.4 MB
2025-03-27 21:41
FORM POS AM
English 1.4 MB
2025-03-27 21:40
FORM POS AM
English 1.4 MB
2025-03-27 21:40
FORM POS AM
English 1.4 MB
2025-03-27 21:40
FORM POS AM
English 1.4 MB
2025-03-27 21:05
FORM 10-K
English 1.4 MB
2025-03-25 21:14
FORM 8-K
English 497.2 KB
2025-03-25 13:45
FORM 424B5
English 167.5 KB
2025-02-14 23:35 English 10.0 KB
2025-01-22 22:01
FORM 8-K
English 70.7 KB
2024-12-18 22:09
FORM 8-K
English 72.6 KB
2024-11-18 22:02
FORM 8-K
English 70.8 KB

Automate Your Workflow. Get a real-time feed of all GeoVax Labs, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeoVax Labs, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeoVax Labs, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ceres Power Holdings PLC Logo
A developer of solid oxide technology for clean power and green hydrogen production.
United Kingdom
CWR
Certara, Inc. Logo
Accelerates drug development using biosimulation software, technology, and services.
United States of America
CERT
CervoMed Inc. Logo
A clinical-stage biotech developing treatments for age-related neurologic disorders.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and provides CDMO and bio-banking services.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
A CRO providing end-to-end solutions to accelerate oncology drug development.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
A contract research organization supporting drug discovery and development.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech company developing antibody-based therapeutics.
Japan
4583
Chordate Medical Holding AB Logo
Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops and licenses plant traits using non-GMO precision gene-editing technology.
United States of America
CBUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.